Validity of Osteoprotegerin and Receptor Activator of NF-κB Ligand for the Detection of Bone Metastasis in Breast Cancer

Osteoprotegerin (OPG) is a robust antiresorptive molecule that acts as a decoy receptor for the receptor activator of nuclear factor κB ligand (RANKL), the mediator of osteoclastogenesis. This study was designed to explore the possible role of serum OPG and RANKL in detecting bone metastasis in brea...

Descripción completa

Detalles Bibliográficos
Autores principales: Elfar, Gamal A., Ebrahim, Mohamed A., Elsherbiny, Nehal M., Eissa, Laila A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cognizant Communication Corporation 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841017/
https://www.ncbi.nlm.nih.gov/pubmed/27983911
http://dx.doi.org/10.3727/096504016X14768398678750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841017/
https://www.ncbi.nlm.nih.gov/pubmed/27983911
http://dx.doi.org/10.3727/096504016X14768398678750

Ejemplares similares